News results

Showing 41 - 50 of 1508 results

First of their kind Guidelines Provide Recommendations for Treating Mood and Anxiety Disorders in Pregnancy and Postpartum

| Health Canada | news releases

Today, the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, alongside Dr. Simone Vigod, Head of the Department of Psychiatry at Women’s College Hospital, and Dr. Benicio Frey, Professor in the Department of Psychiatry and Behavioural Neurosciences, McMaster University, highlighted the publication of the Canadian Network for Mood and Anxiety Treatments (CANMAT) 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders in the Canadian Journal of Psychiatry.


Canada signs a bilateral agreement for $5.3 million with Northwest Territories to strengthen support for personal support workers

| Health Canada | news releases

Michael McLeod, Member of Parliament for the Northwest Territories, on behalf of the Honourable Mark Holland, Canada’s Minister of Health, and the Honourable Lesa Semmler, Minister of Health and Social Services for the Northwest Territories, announced a bilateral agreement to invest $5.3 million over five years to support PSWs across the Northwest Territories (NWT).


Federal Provincial Territorial Health Ministers' Meeting

| Health Canada | statements

The annual meeting of Canada's Federal, Provincial and Territorial (FPT) Ministers of Health was held in Halifax, Nova Scotia from January 29 to 30, 2025. Ministers discussed shared priorities within the health sector, including the health workforce, digital health and health data, mental health and substance use, public health, and pharmaceuticals.


Health Canada publishes proposed changes to increase oversight for precursor chemicals and drug equipment

| Health Canada | news releases

The Government of Canada is concerned with the impact of illegal synthetic drugs on the overdose crisis and on public safety, including security challenges associated with their illegal production, importation, trafficking, and related crimes. Health Canada plays a critical role in supporting Canadian law and border enforcement in their activities to counter the global synthetic drug threat and is taking concrete action to keep communities safe on both sides of the border.


Drugs for Rare Diseases – Ontario Agreement

| Health Canada | backgrounders

Today, the Governments of Canada and the province of Ontario signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $535 million over three years to improve access to new drugs for rare diseases for Ontario residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.


Page details

Date modified: